← Eichor
Study identifier: NCT06208345 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Life Intervention in Pediatrics Supported by E-health

Condition: Adiposity · Childhood Obesity · Adolescent Obesity  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseNA
Planned participants148
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersNo

About this study

Childhood obesity in early life contributes to the development of specific NCDs, i.e. adult obesity. Unhealthy diet and low level of physical activity are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of NCDs. Early preventive measures to improve lifestyle behavior are of utmost importance. The aim of ELIPSE-I is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering total energy intake/total energy expenditure (TEI/TEE) ratio in their children with BMI \>97 centile (ELIPSE-I).

This description comes directly from the study's public registry record.

Talk to the study team

Matthias V. Kopp, Prof. Dr.  ·  +41 31 66 4 13 51  ·  matthias.kopp@insel.ch

Saner Christoph, PhD Dr.  ·  +41 31 63 2 95 52  ·  christoph.saner@insel.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Paediatrics, Inselspital, Bern University HospitalBern, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06208345